--- name: Axcelead Drug Discovery Partners, Inc. slug: axcelead site: cro website_domain: axcelead.com summary: Axcelead provides integrated drug discovery research services across small molecules, nucleic acids, antibodies, and peptides, with specialized expertise in oncology, immunology, and neurology. Founded in 2017 from Takeda's research base, the company serves pharmaceutical companies, bioventures, and academia with above-industry screening hit rates and project success metrics. tagline: Integrated drug discovery platform supporting small molecules, nucleic acids, antibodies, and peptides across oncology, immunology, and neurology. founded_year: 2017 employee_count_band: employee_count_label: parent_name: parent_slug: hq_country: tier2_domain_verified: false updated_at: 2026-09-22T07:02:38.987Z services_count: 27 modalities_count: 6 indications_count: 6 locations_count: 0 review_signal_gate: closed generated_by: BioBM Editorial AI --- # Axcelead Drug Discovery Partners, Inc. Integrated drug discovery platform supporting small molecules, nucleic acids, antibodies, and peptides across oncology, immunology, and neurology. Listed on cro.directory. ## Summary Axcelead provides integrated drug discovery research services across small molecules, nucleic acids, antibodies, and peptides, with specialized expertise in oncology, immunology, and neurology. Founded in 2017 from Takeda's research base, the company serves pharmaceutical companies, bioventures, and academia with above-industry screening hit rates and project success metrics. ## At a glance - Founded: 2017 ## Services - Discovery Research - Target Identification & Validation - High-Throughput Screening - Medicinal Chemistry - Computational & In-Silico Drug Discovery - In Vitro Pharmacology - In Vitro ADME / DMPK - Safety Pharmacology - Genetic Toxicology - In Vivo PK / PD Studies - In Vivo Efficacy Models - Preclinical In Vivo Studies - Preclinical In Vitro Studies - Specialized & Large-Animal Models - GLP Toxicology - Biomarker Assays - Flow Cytometry Services - Bioanalysis - Bioinformatics & Data Science - Genomics & Sequencing Services - Proteomics Services - Pathology & Histology Services - Translational Research - Oncology Specialty Services - Immunology & Inflammation Services - CNS Specialty Services - Cardiovascular & Metabolic Specialty Services ## Modalities - Small Molecule - Oligonucleotide - Antibody-Drug Conjugate (ADC) - Biologics (Monoclonal Antibodies) - Peptide - mRNA ## Indications - Oncology - Immunology - Neurology - Nephrology - Metabolic - Cardiovascular ## Long description ## Overview Axcelead Drug Discovery Partners is a contract research organization established in 2017 to support healthcare innovation by leveraging Takeda Pharmaceutical's drug discovery research foundation. The company operates as a trusted drug discovery solution provider, serving diverse pharmaceutical players—including domestic pharma, global megapharma, bioventures, and academic institutions—with an integrated discovery platform. ## Core Capabilities **Drug Discovery Services:** - Lead generation and lead optimization (LG/LO) with above-industry screening hit rates - Medicinal chemistry (computational chemistry, parallel synthesis, flow chemistry) - High-throughput screening (HTS) and phenotypic screening - iPS cell-based compound screening - Compound library management and custom small-molecule libraries **Biology & Mechanism:** - Genetically modified mouse and rat creation and evaluation - Disease model animals (chronic kidney disease models, hydrodynamics-based models) - Omics services: mechanism exploration, biomarker discovery, bioinformatics - Single-cell and single-nucleus analysis - Spatial transcriptomics - Flow cytometry-based research **Nucleic Acid Therapeutics:** - Off-target effect evaluation for nucleic acid drugs (total service) - miRNA analysis - RNA splicing-directed drug discovery **Chemistry & ADMET:** - HT-ADMET and parenteral formulation development - Development candidate synthesis and modeling/simulation - Analytical chemistry and synthetic chemistry **Safety & Efficacy:** - In vitro toxicity screening, hERG assays, phototoxicity evaluation - Cardiovascular safety assessment and mechanism-of-action analysis - In vivo efficacy and pharmacokinetics/pharmacodynamics studies **Therapeutic Modalities:** - Small molecules (including protein degradation inducers) - RNA modulators - Peptide therapeutics - Nucleic acid drugs - Regenerative medicine and mRNA therapeutics **Disease Expertise:** - Oncology (cancer immunotherapy drug discovery, tumor microenvironment research, syngeneic transplant models) - Immunology (flow cytometry-driven research) - Neurology and neuromuscular disease - Nephrology (chronic kidney disease) - Metabolic disease (MASH, obesity) - Cardiovascular disease (heart failure, echocardiography-based translational bridging) ## Client Base & Performance Axcelead works with nearly all domestic Japanese pharmaceutical companies investing in drug discovery research and maintains significant relationships with global megapharma. The company is positioned as a trusted partner for addressing unmet medical needs in oncology, immunology, and central nervous system disorders. Demonstrated above-industry screening hit rates and project goal achievement rates reflect the expertise of experienced researchers who previously led drug discovery at major pharmaceutical companies. ## Related companies - [BioDuro-Sundia](/companies/bioduro-sundia) (Discovery Research, Target Identification & Validation) — [Compare](/compare/axcelead/bioduro-sundia) - [Reaction Biology](/companies/reactionbiology) (Discovery Research, Target Identification & Validation) — [Compare](/compare/axcelead/reactionbiology) - [ChemPartner](/companies/chempartner) (Discovery Research, Target Identification & Validation) — [Compare](/compare/axcelead/chempartner) - [ChemDiv](/companies/chemdiv) (Discovery Research, Target Identification & Validation) — [Compare](/compare/axcelead/chemdiv) - [Crown Bioscience](/companies/crownbio) (Discovery Research, In Vitro Pharmacology) — [Compare](/compare/axcelead/crownbio) - [Oncodesign Services](/companies/oncodesign-services) (Discovery Research, Target Identification & Validation) — [Compare](/compare/axcelead/oncodesign-services) - [Aragen Life Sciences](/companies/aragen) (Discovery Research, Target Identification & Validation) — [Compare](/compare/aragen/axcelead) - [Inotiv](/companies/inotivco) (In Vitro Pharmacology, Safety Pharmacology) — [Compare](/compare/axcelead/inotivco) _Profile last updated: 2026-09-22T07:02:38.987Z. Profile facts may include AI-assisted enrichment._ Auto-generated by BioBM Editorial AI for machine-readable profile access.